Early detection is a game-changer for patients with inherited retinal diseases (IRDs). In this episode of the EURETINA IME video interview series, Profs. Bart Leroy and Hélène Dollfus highlight why timely diagnosis, regular follow-ups, and referrals to specialized centers are vital. These steps ensure patients receive comprehensive assessments, including cutting-edge functional and genetic testing.

The discussion also delves into the effectiveness of current treatments, the barriers many patients face in accessing care, and the pressing need to raise awareness and education for both patients and healthcare providers.

Looking to stay ahead in IRD care? Watch this episode and explore the entire series to deepen your understanding.

Independent medical education supported by Johnson & Johnson, Neurotech Pharmaceuticals, and Alkeus Pharmaceuticals.